Intellipharmaceutics
30 Worcester Road
Toronto
Ontario
M9W 5X2
Canada
Tel: 416-798-3001
Fax: 416-798-3007
Website: http://www.intellipharmaceutics.com/
163 articles about Intellipharmaceutics
-
IntelliPharmaCeutics' Co-founders Selected for Science and Technology Award
10/5/2010
-
IntelliPharmaCeutics to Present at JMP Securities Healthcare Conference
9/24/2010
-
IntelliPharmaCeutics to Present at JMP Securities Healthcare Conference
9/23/2010
-
IntelliPharmaCeutics Announces Second Quarter 2010 Results
7/15/2010
-
IntelliPharmaCeutics Provides Update on Activities Related to Venlafaxine Hydrochloride Extended Release Capsules
7/6/2010
-
IntelliPharmaCeutics Files ANDA With the FDA for Generic Protonix(R)
6/14/2010
-
IntelliPharmaCeutics Announces Significant Advance in Its Abuse-Deterrent Oxycodone Program
5/21/2010
-
FDA Accepts for Filing IntelliPharmaCeutics' ANDA for Generic Effexor XR(R)
5/7/2010
-
IntelliPharmaCeutics Announces Approval of Settlement Related to ADHD Drug Focalin XR(R)
5/6/2010
-
IntelliPharmaCeutics Announces First Quarter 2010 Results
4/14/2010
-
IntelliPharmaCeutics Announces Settlement for its Generic Version of Focalin XR(R)
3/12/2010
-
IntelliPharmaCeutics Announces 2009 Eleven Month Period End Results
3/1/2010
-
IntelliPharmaCeutics to Host Conference Call and Webcast on March 1, 2010 at 10:00 a.m. Eastern Time
2/23/2010
-
IntelliPharmaCeutics Announces Appointment of Chief Financial Officer
2/12/2010
-
IntelliPharmaCeutics and Vasogen Complete Arrangement to Create Publicly-traded Specialty Pharmaceutical Company
10/22/2009
-
Vasogen and IntelliPharmaCeutics Jointly Announce Shareholder Approval of Plan of Arrangement and Merger
10/20/2009
-
Vasogen and IntelliPharmaCeutics to Combine to Create Publicly-traded Specialty Pharmaceutical Company; Vasogen Also Raises $7.5 Million
8/17/2009
-
IntelliPharmaCeutics Provides Update on Activities
8/11/2008
-
IntelliPharmaCeutics Announces Successful Completion of a Pilot Clinical Trial for its Abuse and Alcohol Resistant Sustained Release Oxycodone
3/28/2008
-
IntelliPharmaCeutics Announces Successful Completion of a Pilot Clinical Trial for its Abuse and Alcohol Resistant Sustained Release Oxycodone
3/27/2008